Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Remimazolam has demonstrated the potential as a valuable medication for procedural sedation and general anesthesia. However, the effective dosage of remimazolam in pediatric patients is still unknown.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| remimazolam | Experimental | remimazolam is given for anesthesia induction |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Remimazolam | Drug | remimazolam is given intravenously |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| half effective dosage | the dosage by which half of the patients will be sedated | from injection of remimazolam to loss of consciousness, at an average of 5 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| 95% effective dosage | the dosage by which 95% of the patients will be sedated | from injection of remimazolam to loss of consciousness, at an average of 5 minutes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37333966 | Result | Tan H, Lou AF, Wu JE, Chen XZ, Qian XW. Determination of the 50% and 95% Effective Dose of Remimazolam Combined with Propofol for Intravenous Sedation During Day-Surgery Hysteroscopy. Drug Des Devel Ther. 2023 Jun 13;17:1753-1761. doi: 10.2147/DDDT.S406514. eCollection 2023. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C522201 | remimazolam |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided